학술논문
27030 Extended safety analysis of baricitinib 2-mg in adult patients with atopic dermatitis: An integrated analysis from 8 randomized clinical trials
Document Type
Abstract
Author
Source
In Journal of the American Academy of Dermatology September 2021 85(3) Supplement:AB127-AB127
Subject
Language
ISSN
0190-9622